Calin A, Bennett R M, Sukhupunyaraksa S, Goldman A L, Montoya H E, O'Brien W M, Giuliano V J, Schmid F R, Willkens R F, Sakofsky H Y
J Rheumatol. 1977 Summer;4(2):153-7.
A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.
对102例类风湿性关节炎(RA)患者进行了一项双盲平行多中心研究,在三个月的时间里比较布洛芬(每日1200 - 2400毫克)和酮洛芬(每日150 - 300毫克,一种新型非甾体抗炎药)。酮洛芬耐受性良好,且显示出与布洛芬相当的疗效。有必要进行长期疗效和耐受性研究。